Differential [ 3 H]idazoxan and [ 3 H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) binding to imidazoline I 2 receptors in human postmortem frontal cortex

By Callado L.F.   Maeztu A.I.   Ballesteros J.   Gutierrez M.   Javier Meana J.  

European Journal of Pharmacology, Vol. 423, Iss. 2, 2001-07 ,pp. : 109-114

Elsevier

Access to resources Recommend Favorite

Imidazoline Binding Sites and Receptors in Cardiovascular Tissue - an investigation into their relationship to imidazoline, 2 and H 3 receptors

By Molderings G.J.   Gothert M.  

General Pharmacology, Vol. 32, Iss. 1, 1999-01 ,pp. : 17-22

Elsevier

Access to resources Recommend Favorite

Region-dependent effects of acute and chronic tranylcypromine in vivo on [ 3 H]2-BFI binding to brain imidazoline I 2 sites

By MacInnes N.   Handley S.L.  

European Journal of Pharmacology, Vol. 428, Iss. 2, 2001-10 ,pp. : 221-225

Elsevier

Access to resources Recommend Favorite

Characterisation and localisation of [ 3 H]2-(2-benzofuranyl)-2-imidazoline binding in rat brain: a selective ligand for imidazoline I 2 receptors

By Lione L.A.   Nutt D.J.   Hudson A.L.  

European Journal of Pharmacology, Vol. 353, Iss. 1, 1998-07 ,pp. : 123-135

Elsevier

Access to resources Recommend Favorite

Polyclonal anti-idiotypic antibodies to idazoxan and their interaction with human brain imidazoline binding sites

By Bennai F.   Greney H.   Vonthron C.   Bousquet P.   Dontenwill M.  

European Journal of Pharmacology, Vol. 306, Iss. 1, 1996-06 ,pp. : 211-218

Elsevier

Access to resources Recommend Favorite